Format

Send to

Choose Destination
Theranostics. 2013 Nov 29;3(12):930-42. doi: 10.7150/thno.7026.

MicroRNAs -the next generation therapeutic targets in human diseases.

Author information

1
1. Lee Kong Chian School of Medicine, Nanyang Technological University, 50 Nanyang Drive, Research Techno Plaza, Level 4, X-Frontier Block, Singapore-637553.
2
2. Institute of Materials Research and Engineering, 3 Research Link, Singapore-117602.
3
3. Centre for Pheromone Technology (CPT), Department of Animal Science, Bharathidasan University, Tiruchirappalli- 620 024, India.

Abstract

MicroRNAs (miRNAs), an abundant class of ~22-nucleotide non-coding RNAs, regulate the expression of genes at post transcriptional level. MiRNAs are important regulators of eukaryotic gene expression and therefore implicated in a wide range of biological processes. The miRNA-related genetic alterations are possibly more implicated human diseases than currently appreciated. Genetic variants in miRNA target sites, called miRNA genes are identified to be associated with human diseases. This review discusses about the role of micro-RNA genes in various human diseases such as neurodegenerative disorders, cardio-vascular diseases, and metabolic disorders, and how they can be targeted as a new therapeutic tool in future with reference to drug discoveries/ development.

KEYWORDS:

Cardio-vascular diseases and metabolic disorders; Neurodegenerative disorders; miRNA therapy; novel therapeutics

PMID:
24396504
PMCID:
PMC3881095
DOI:
10.7150/thno.7026
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ivyspring International Publisher Icon for PubMed Central
Loading ...
Support Center